Next Article in Journal
Inhibition of Sphingosine Kinase 1 Reduces Sphingosine-1-Phosphate and Exacerbates Amyloid-Beta-Induced Neuronal Cell Death in Mixed-Glial-Cell Culture
Next Article in Special Issue
Continuous Research of Headache and Migraine
Previous Article in Journal
The Effect of Repetitive Transcranial Magnetic Stimulation on Cognition in Diffuse Axonal Injury in a Rat Model
Previous Article in Special Issue
Effects of Anti-CGRP Monoclonal Antibodies on Neurophysiological and Clinical Outcomes: A Combined Transcranial Magnetic Stimulation and Algometer Study
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Case Report

A Case of Idiopathic Intracranial Hypertension Complicated with both Infratentorial and Supratentorial Cortical Superficial Siderosis: Novel Imaging Findings on Intravoxel Incoherent Motion Magnetic Resonance Imaging Offering Clues to Pathophysiology

1
Department of Neurosurgery, Mito Kyodo General Hospital, Tsukuba University Hospital Mito Area Medical Education Center, Mito, 3-2-7 Miyamachi, Ibaraki 310-0015, Japan
2
Department of Neurosurgery, Institute of Medicine, University of Tsukuba, 2-1-1, Amakubo, Tsukuba, Ibaraki 305-8576, Japan
*
Author to whom correspondence should be addressed.
Neurol. Int. 2024, 16(4), 701-708; https://doi.org/10.3390/neurolint16040053
Submission received: 24 May 2024 / Revised: 24 June 2024 / Accepted: 27 June 2024 / Published: 28 June 2024

Abstract

:
The pathology of idiopathic intracranial hypertension (IIH), a disease characterized by papillary edema and increased intracranial pressure (IICP), is not yet understood; this disease significantly affects quality of life due to symptoms including vision loss, headache, and pulsatile tinnitus. By contrast, superficial siderosis (SS), a disorder in which hemosiderin is deposited on the surface of the cerebral cortex and cerebellum, potentially causes cerebellar ataxia or hearing loss. So far, no cases of IIH with infratentorial and supratentorial cortical SS have been reported. Herein, we report a case of a 31-year-old woman with obesity who developed this condition. The patient suddenly developed headache and dizziness, had difficulty walking, and subsequently became aware of diplopia. Fundus examination revealed bilateral optic nerve congestive papillae and right eye abducens disturbance. Head magnetic resonance imaging (MRI) showed prominent SS on the cerebellar surface and cerebral cortex. Lumbar puncture revealed IICP of 32 cmH2O, consistent with the diagnostic criteria for IIH, and treatment with oral acetazolamide was started; subsequently, the intracranial pressure decreased to 20 cmH2O. Her abduction disorder disappeared, and the swelling of the optic papilla improved. She was now able return to her life as a teacher without any sequelae. SS is caused by persistent slight hemorrhage into the subarachnoid space. In this case, both infratentorial and supratentorial cortical superficial SS was observed. Although cases of IIH complicated by SS are rare, it should be kept in mind that a causal relationship between IIH and SS was inferred from our case. Our findings also suggest that cerebrospinal fluid dynamic analysis using MRI is effective in diagnosing IIH and in determining the efficacy of treatment.

1. Introduction

Idiopathic intracranial hypertension (IIH) is characterized by increased intracranial pressure as indicated by papilledema and imaging findings, with no identifiable extrinsic causes [1]. The main symptoms are headache, vision loss, and pulsatile tinnitus, which are known to significantly affect quality of life and visual function [1]. The cause is unknown but is thought to involve overproduction of cerebrospinal fluid (CSF), absorption disorders, impaired venous return, and metabolic disorders [2]. The incidence is known to be higher in obese women of reproductive age [3] at approximately 5.5 per 100,000 per year [4], while the reported overall incidence is approximately 1 to 2 per 100,000 per year [4,5,6]. The overarching goal of treatment is to alleviate symptoms and prevent permanent vision loss. It has been reported that IIH can also be treated by treating obesity [7]. On the other hand, superficial siderosis (SS) is a disorder in which hemosiderin is deposited on the cortical surface of the cerebrum or cerebellum, and although hemorrhagic tendency, tumors, trauma, and spinal disease are classic known hemorrhagic factors, the cause of SS is also frequently unknown [8]. Persistent hemorrhage owing to spinal cord dural defects resulting from injury has also been implicated [9] and categorized as “duropathy” [10,11]. An association between spontaneous intracranial hypotension (SIH) and SS has also been reported [12,13]. However, so far, no cases of IIH with infratentorial and supratentorial cortical SS have been reported.
We encountered a very rare case of IIH complicated by infratentorial and supratentorial cortical SS. We aimed to report this case because of its clinical significance, as we uncovered novel findings in a patient with IIH that could aid in elucidating its pathology.

2. Case Description

This report was approved by the Institutional Review Board of Mito Kyodo General Hospital and was registered under the clinical trial registration number, IRB NO 23-09. We obtained written informed consent from the patient for reporting this case.
A 31-year-old woman with obesity developed sudden headache and dizziness 13 days before hospital admission, following which vomiting continued for 3 days. Next, she lost strength in her legs and had difficulty walking. Subsequently, her headache, nausea, and dizziness, which peaked during the aforementioned 3 days, gradually subsided. Seven days before her admission, she became aware of diplopia when she turned her head to the right side. On the day of emergent admission, she visited an ophthalmologist at a nearby clinic and was referred to our hospital because of congestive papillae in both eyes and marked abduction disorder in the right eye. She also experienced dizziness during eye movements. On visiting our hospital, the patient was unable to walk independently. She did not smoke, drank alcohol only once per week, and had no history of allergies. She was Irish, had never been married or given birth, and was a middle school English teacher. She had a medical history of migraine with aura since puberty. Her most recent oral medications included eletriptan hydrobromide, lomerizine hydrochloride, domperidone, and herbal remedies for migraine. She had been on the pill until approximately 1.5 months ago but had stopped taking it on the advice of her family doctor due to an increased risk of stroke. She had no notable family history. Physical examination revealed obesity, with a height of 162 cm, weight of 80 kg, and body mass index of 30.5. Her awareness score was 15 (4-5-6) points on the Glasgow Coma Scale. On ophthalmologic examination, corrected visual acuity was 1.5 in both the right and left eyes, and intraocular pressure was not elevated (right eye: 13.5 mmHg, left eye: 13.0 mmHg); however, fundus findings showed significant swelling of both optic nerve papillae, which were stasis-like (Figure 1).
The cranial nervous system assessment revealed the following: prompt pupillary counter-reflexes, pupillary size of 3.0 mm, abducent nerve disturbances in the right eye, and absence of facial paralysis and dysarthria. An assessment of the motor system revealed a negative Barre’s sign and grade of 5/V on the Manual Motor Test in both the upper and lower limbs. No obvious sensory disturbances were observed in the whole body. The coordination of hand rotation was smooth. Her blood data showed no abnormalities in blood counts or general biochemistry and no hyperlipidemia or diabetes mellitus, and D-dimer levels were not elevated in the coagulation system.
Head magnetic resonance imaging (MRI) (Figure 2) revealed multiple prominent hemosiderin deposits on the cerebellar surface and similar hemosiderin deposits in the temporal lobe and fissure sylviae, indicating infratentorial and cortical SS.
Computed tomography (CT) showed no acute hemorrhage. CT venography (Figure 3) showed bilateral stenosis of the transverse sinus or bilateral dilatation of the adjoining vein of Labbe.
Lumbar puncture on day 1 after her admission showed an increased intracranial pressure of 32 cmH2O, and the following were the laboratory findings in the CSF sample: colorless and transparent CSF, specific gravity of 1.006 (normal range: 1.005–1.007), glucose level of 78 mg/dL (normal range: 40–75), protein level of 25 mg/dL (normal range: 10–40), and cell count of 4/3. Additional laboratory tests showed no notable findings. Therefore, she was diagnosed with IIH because no other disease that could cause her symptoms was apparent, and there was no obvious cause of intracranial hypertension, such as an occupying lesion, which aligned with the modified Dandy criteria [14] for the diagnosis of IIH. Treatment with oral acetazolamide (750 mg/day) was started. Approximately 3 days after treatment initiation, the abduction disorder in the patient’s right eye almost disappeared, her dizziness disappeared, and she was able to walk unassisted. Ten days from admission, the patient was discharged on her own. Twenty-two days from admission, a follow-up lumbar puncture showed a decreased intracranial pressure of 20 cmH2O, and the following were the laboratory findings in the CSF sample: colorless and transparent CSF, specific gravity of 1.006 (normal range: 1.005–1.007), glucose level of 68 mg/dL (normal range: 40–75), protein level of 40 mg/dL (normal range: 10–40), and cell count of 5/3. Sixty-three days from admission, on examination by the ophthalmologist, all findings had improved. Dynamic visual field testing showed that although the enlargement of Mariotte’s blind spot was still present and not yet normalized, it had shrunk. Ocular position testing showed that the strabismus and eye movement disorder had disappeared. Fundus examination showed that the swelling of the optic nerve papilla had improved, with only slight residual swelling left, and the subjective complaints of diplopia were no longer present. Seventy-one days from admission, head MRI showed no change in intracranial SS, and spinal MRI showed no CSF leakage that could be a cause of infratentorial siderosis. All of her aftereffects had disappeared, as evidenced by a modified Rankin scale score of 0, and she returned to her pre-onset life as a teacher.
Intravoxel incoherent motion (IVIM) MRI, which was used to visualize CSF movement [15], using the IVIM Map (FUJIFILM Corporation), showed (Figure 4) that the SS site matched the area of strong incoherent CSF motion at the time of pre-treatment in our case as well.
In the IICP condition, incoherent CSF movement was pronounced in the caudal portion of the medulla oblongata, fourth ventricle, lateral ventricles, and brain surface; however, in the decreased intracranial pressure condition following acetazolamide treatment, the incoherent movement in these regions decreased (Table 1).

3. Discussion

In this case, a young woman with obesity and IIH developed sudden onset headache and nausea, followed by right eye abduction disorder and papilledema. The patient had marked SS in both the infratent and supratent. There have been no previous reports of IIH patients with both infratentorial and supratentorial SS. IVIM MRI was performed to visualize the movement of the CSF (clinical trial registration number: Mito Kyodo General Hospital IRB No. 23-09), suggesting a causal relationship between IIH and SS. Therefore, this report is highly novel and of high clinical significance as it provides insights into the relationship between IIH and SS and has revealed novel imaging findings, which could be clues regarding the pathophysiology.

3.1. Causal Relationship between IIH and SS

SS of the central nervous system is characterized by linear hemosiderin deposition in the superficial layers of the leptomeninges, cerebrum, and spinal cord [16]. Subarachnoid space infratentorial SS is thought to be caused by recurrent or continuous slight hemorrhage into the subarachnoid space, with the most important cause being spinal dural lesions that cause CSF leakage [16]. The classical types of infratentorial SS have been reported to involve dural abnormalities, spinal CSF leakage, craniocervical surgery, spinal trauma, head trauma, arteriovenous malformation (AVM), and tumors, while the secondary types involve subarachnoid hemorrhage (SAH), AVM, and cerebral venous embolism due to ruptured cerebral aneurysm [16]. The other types of SS have been classified into SS confined to the supratentorial compartment or cortical SS. Supratentorial cortical SS involves cerebral amyloid angiopathy in the elderly, ruptured cerebral aneurysmal SAH, AVM, reversible cerebral vasoconstriction syndrome, amyloid-related imaging abnormalities due to hemosiderin deposition, vasculitis, severe stenosis of the cerebral vessels, sinus occlusion, head trauma, and tumors [16].
In the present case, hemosiderin deposition was observed above and below the tent. However, there was no obvious cause of SS. There were no findings in the CSF specimen that would suggest persistent hemorrhage due to CSF leakage, as described in classical SS; similarly, head and spinal cord MRI findings did not reveal the presence of any disease that could have caused SS. However, the possibility that IIH may have caused the onset of SS due to arachnoid damage could not be ruled out although this has not been previously reported. Therefore, it should be kept in mind that IIH may cause SS due to arachnoid membrane rupture, which is a newly identified cause of SS.
Conversely, to the best of our knowledge, there are no reports regarding the possibility of IIH caused by SS which have documented the mechanisms of IIH, such as CSF malabsorption associated with SS. However, it is important to accumulate case reports similar to ours in the future.

3.2. Was SS Asymptomatic in This Case?

Typical neurological manifestations of infratentorial SS include slowly progressive sensorineural hearing impairment and cerebellar manifestations, such as ataxia, motor tremor, nystagmus, and dysarthria [8,9,17,18,19,20,21,22]. There are reported cases in which hemosiderin deposition in the cranial nerves has caused the appearance of individual cranial nerve symptoms [23].
The patient’s main symptoms of congestive papillae and abducens nerve palsy disappeared due to a successful response to acetazolamide and decrease in intracranial pressure; therefore, we believe that these symptoms were not caused by SS but by IIH. However, it is undeniable that the abducens nerve palsy in our patient at the time of intracranial hypertension onset may have been influenced by hemosiderin deposition in the cranial nerves.

3.3. Did SS Affect the Clinical Course of IIH?

In cerebral surface hemosiderin deposition disease, hemosiderin in the blood is deposited on the surface of the brain and spinal cord due to persistent and repeated bleeding, causing nerve damage due to oxidative stress [24]. At the time of admission, there were no acute hemorrhagic changes that could have resulted in a high signal on CT, and we believe that hemosiderin deposition was originally part of the patient’s previous history. MRI at the time of admission also showed hemosiderin deposition in the abducens nerve; however, we cannot rule out the possibility that neuropathy caused by oxidative stress may have precipitated the appearance of abducens nerve palsy due to IICP, although not to the extent that it caused continuous subjective symptoms.

3.4. CSF Circulation in IIH with SS

We were not able to find reports on CSF dynamics in IIH in the literature. Recently, IVIM MRI was used to visualize CSF movement [15]. In this case, the SS site matched the area of strong incoherent CSF motion at the time of pre-treatment. Our finding of incoherent CSF movement supports the association between IIH and SS.
The combination of SS and IIH has not been previously reported. However, SIH could cause SS by a CSF leak [12,13]. There were some reports of SIH converting to IIH by spontaneous closure of the leak. Sulioti et al. reported a case of a patient with IIH developing SIH and concluded that the implication of a possible causative link between elevated CSF pressure and subsequent development of dural rupture and SIH raises important questions regarding the pathophysiology of SIH in some cases [25]. Some reports revealed that increased craniospinal elastance can lead to elevated ICP, which is pathological in IIH and compensatory in SIH [26,27]. Parikh et al. reported on spontaneous decompression from underlying IIH as a possible etiology of SIH [28]. Similar to the findings in these previous cases, it is not impossible that the patient in our case had potential SIH and associated SS and developed IIH with the natural closure of the leak.

3.5. Limitations

This study had the following limitation. IVIM MRI may be subject to susceptibility artifacts; however, we confined the measurement area to a much smaller region of interest when performing the value measurements as a countermeasure to overcome this concern.

4. Conclusions

This is the first reported case of IIH with underlying cerebral surface hemosiderin deposition both above and below the tent; there was no obvious condition, such as CSF leakage, which could have caused SS, suggesting a causal relationship between IIH and SS. CSF analysis using IVIM MRI may be effective for diagnosing IIH and determining treatment efficacy.

Author Contributions

Conceptualization, S.W. and Y.S.; methodology, S.W. and Y.S.; software, S.W.; validation, Y.S.; resources, S.W.; data curation, S.W.; writing—original draft preparation, S.W.; writing—review and editing, all authors.; supervision, E.I.; All authors have read and agreed to the published version of the manuscript.

Funding

This work was supported by JSPS KAKENHI Grant Number JP21K16627 and JP24K12215.

Institutional Review Board Statement

The study was conducted in accordance with the Declaration of Helsinki and approved by the Institutional Review Board of Mito Kyodo General Hospital (IRB number: NO 23-09 and date of approval: 7 August 2023).

Informed Consent Statement

Informed consent was obtained from all subjects involved in the study, and written informed consent has been obtained from the patient to publish this paper.

Data Availability Statement

The original contributions presented in the study are included in the article, and further inquiries can be directed to the corresponding author.

Acknowledgments

The authors would like to thank the Radiation Department of Mito Kyodo General Hospital for the support in performing the measurements.

Conflicts of Interest

The authors declare no conflicts of interest.

References

  1. Wang, M.T.M.; Bhatti, M.T.; Danesh-Meyer, H.V. Idiopathic intracranial hypertension: Pathophysiology, diagnosis and management. Rev. J. Clin. Neurosci. 2022, 95, 172–179. [Google Scholar] [CrossRef] [PubMed]
  2. Markey, K.A.; Mollan, S.P.; Jensen, R.H.; Sinclair, A.J. Understanding idiopathic intracranial hypertension: Mechanisms, management, and future directions. Lancet Neurol. 2016, 15, 78–91. [Google Scholar] [CrossRef] [PubMed]
  3. Wall, M.; George, D. Idiopathic intracranial hypertension. A prospective study of 50 patients. Brain 1991, 114 Pt 1A, 155–180. [Google Scholar]
  4. Kesler, A.; Stolovic, N.; Bluednikov, Y.; Shohat, T. The incidence of idiopathic intracranial hypertension in Israel from 2005 to 2007, results of a nationwide survey. Eur. J. Neurol. 2014, 21, 1055–1059. [Google Scholar] [CrossRef] [PubMed]
  5. Durcan, F.J.; Corbett, J.J.; Wall, M. The incidence of pseudotumor cerebri. Population studies in Iowa and Louisiana. Arch. Neurol. 1988, 45, 875–877. [Google Scholar] [CrossRef] [PubMed]
  6. Radhakrishnan, K.; Ahlskog, J.E.; Cross, S.A.; Kurland, L.T.; O’Fallon, W.M. Idiopathic intracranial hypertension (pseudotumor cerebri). Descriptive epidemiology in Rochester, Minn, 1976 to 1990. Arch. Neurol. 1993, 50, 78–80. [Google Scholar] [CrossRef] [PubMed]
  7. Subramaniam, S.; Fletcher, W.A. Obesity and weight loss in idiopathic intracranial hypertension: A narrative review. J. Neuroophthalmol. 2017, 37, 197–205. [Google Scholar] [CrossRef] [PubMed]
  8. Levy, M.; Turtzo, C.; Llinas, R.H. Superficial siderosis: A case report and review of the literature. Nat. Clin. Pract. Neurol. 2007, 3, 54–55. [Google Scholar] [CrossRef] [PubMed]
  9. Wilson, D.; Chatterjee, F.; Farmer, S.F.; Rudge, P.; McCarron, M.O.; Cowley, P.; Werring, D.J. Infratentorial superficial siderosis: Classification, diagnostic criteria, and rational investigation pathway. Ann. Neurol. 2017, 81, 333–343. [Google Scholar] [CrossRef]
  10. Kumar, N. Beyond superficial siderosis: Introducing “duropathies”. Neurology 2012, 78, 1992–1999. [Google Scholar] [CrossRef]
  11. Kumar, N.; Miller, G.M.; Piepgras, D.G.; Mokri, B. A unifying hypothesis for a patient with superficial siderosis, low-pressure headache, intraspinal cyst, back pain, and prominent vascularity. J. Neurosurg. 2010, 113, 97–101. [Google Scholar] [CrossRef] [PubMed]
  12. Mokri, B. Spontaneous intracranial hypotension. Continuum 2015, 21, 1086–1108. [Google Scholar] [CrossRef] [PubMed]
  13. Schievink, W.I.; Maya, M.; Moser, F.; Nuño, M. Long-term risks of persistent ventral spinal CSF leaks in SIH: Superficial siderosis and bibrachial amyotrophy. Neurology 2021, 97, e1964–e1970. [Google Scholar] [CrossRef] [PubMed]
  14. Kosmorsky, G.S. Idiopathic intracranial hypertension: Pseudotumor cerebri. Headache 2014, 54, 389–393. [Google Scholar] [CrossRef] [PubMed]
  15. Yamada, S.; Hiratsuka, S.; Otani, T.; Ii, S.; Wada, S.; Oshima, M.; Nozaki, K.; Watanabe, Y. Usefulness of intravoxel incoherent motion MRI for visualizing slow cerebrospinal fluid motion. Fluids Barriers CNS 2023, 20, 16. [Google Scholar] [CrossRef] [PubMed]
  16. Weidauer, S.; Neuhaus, E.; Hattingen, E. Cerebral superficial siderosis: Etiology, neuroradiological features and clinical findings. Clin. Neuroradiol. 2023, 33, 293–306. [Google Scholar] [CrossRef] [PubMed]
  17. van Harskamp, N.J.; Rudge, P.; Cipolotti, L. Cognitive and social impairments in patients with superficial siderosis. Brain 2005, 128 Pt 5, 1082–1092. [Google Scholar] [CrossRef] [PubMed]
  18. Uttner, I.; Tumani, H.; von Arnim, C.; Brettschneider, J. Cognitive impairment in superficial siderosis of the central nervous system: A case report. Cerebellum 2009, 8, 61–63. [Google Scholar] [CrossRef] [PubMed]
  19. Anderson, N.E.; Sheffield, S.; Hope, J.K. Superficial siderosis of the central nervous system: A late complication of cerebellar tumors. Neurology 1999, 52, 163–169. [Google Scholar] [CrossRef]
  20. Fearnley, J.M.; Stevens, J.M.; Rudge, P. Superficial siderosis of the central nervous system. Brain 1995, 118 Pt 4, 1051–1066. [Google Scholar] [CrossRef]
  21. Bürk, K.; Skalej, M.; Dichgans, J. High prevalence of CSF-containing cysts in superficial hemosiderosis of the central nervous system. J. Neurol. 2001, 248, 1005–1006. [Google Scholar] [CrossRef]
  22. Kumar, N.; Cohen-Gadol, A.A.; Wright, R.A.; Miller, G.M.; Piepgras, D.G.; Ahlskog, J.E. Superficial siderosis. Neurology 2006, 66, 1144–1152. [Google Scholar] [CrossRef] [PubMed]
  23. Savoiardo, M.; Maccagnano, E.; Pareyson, D.; Grisoli, M. Superficial siderosis. Neurology 2007, 68, 62. [Google Scholar] [CrossRef] [PubMed]
  24. Koeppen, A.H.; Michael, S.C.; Li, D.; Chen, Z.; Cusack, M.J.; Gibson, W.M.; Petrocine, S.V.; Qian, J. The pathology of superficial siderosis of the central nervous system. Acta Neuropathol. 2008, 116, 371–382. [Google Scholar] [CrossRef] [PubMed]
  25. Sulioti, G.; Gray, L.; Amrhein, T.J. Popping the balloon: Abrupt onset of a spinal CSF leak and spontaneous intracranial hypotension in idiopathic intracranial hypertension, a case report. Headache 2022, 62, 208–211. [Google Scholar] [CrossRef]
  26. Tsai, Y.H.; Chen, H.C.; Tung, H.; Wu, Y.Y.; Chen, H.M.; Pan, K.J.; Cheng, D.C.; Chen, J.H.; Chen, C.C.C.; Chai, J.W.; et al. Noninvasive assessment of intracranial elastance and pressure in spontaneous intracranial hypotension by MRI. J. Magn. Reson. Imaging 2018, 48, 1255–1263. [Google Scholar] [CrossRef] [PubMed]
  27. Griffith, B.; Capobres, T.; Patel, S.C.; Marin, H.; Katramados, A.; Poisson, L.M. CSF pressure change in relation to opening pressure and CSF volume removed. AJNR Am. J. Neuroradiol. 2018, 39, 1185–1190. [Google Scholar] [CrossRef]
  28. Parikh, S.K. Rebound intracranial hypertension. Curr. Pain Headache Rep. 2024, 28, 395–401. [Google Scholar] [CrossRef]
Figure 1. Congestive papillary findings in idiopathic intracranial hypertension. Fundus findings showed significant swelling of both optic nerve papillae.
Figure 1. Congestive papillary findings in idiopathic intracranial hypertension. Fundus findings showed significant swelling of both optic nerve papillae.
Neurolint 16 00053 g001
Figure 2. Magnetic resonance imaging on admission. SWI showing low intensity findings on the cerebellar hemispheric surfaces and cranial nerves under the cerebellar tent and low intensity findings on cortical surfaces, such as the Sylvian fissure on the tent. FLAIR imaging showing no occupying lesion and no obvious abnormalities. SWI: susceptibility-weighted imaging, FLAIR: fluid attenuated inversion recovery.
Figure 2. Magnetic resonance imaging on admission. SWI showing low intensity findings on the cerebellar hemispheric surfaces and cranial nerves under the cerebellar tent and low intensity findings on cortical surfaces, such as the Sylvian fissure on the tent. FLAIR imaging showing no occupying lesion and no obvious abnormalities. SWI: susceptibility-weighted imaging, FLAIR: fluid attenuated inversion recovery.
Neurolint 16 00053 g002
Figure 3. Computed tomography venography on admission. Computed tomography venography showing bilateral transverse sinus stenosis findings on maximum intensity projection.
Figure 3. Computed tomography venography on admission. Computed tomography venography showing bilateral transverse sinus stenosis findings on maximum intensity projection.
Neurolint 16 00053 g003
Figure 4. IVIM MRI findings showing the intracranial hypertension state and intracranial pressure reduction with acetazolamide administration. (a). IVIM MRI in the intracranial hypertension state before oral acetazolamide treatment, (b). IVIM MRI showing decreased intracranial pressure after oral acetazolamide treatment. IVIM MRI: intravoxel incoherent motion magnetic resonance imaging.
Figure 4. IVIM MRI findings showing the intracranial hypertension state and intracranial pressure reduction with acetazolamide administration. (a). IVIM MRI in the intracranial hypertension state before oral acetazolamide treatment, (b). IVIM MRI showing decreased intracranial pressure after oral acetazolamide treatment. IVIM MRI: intravoxel incoherent motion magnetic resonance imaging.
Neurolint 16 00053 g004
Table 1. Mean f values (%) in IVIM MRI in the IICP state before treatment and decreased ICP state after treatment.
Table 1. Mean f values (%) in IVIM MRI in the IICP state before treatment and decreased ICP state after treatment.
IICP State Decreased ICP State
Foramen magnum70.686.9
Right foramen of Luschka44.389.1
Left foramen of Luschka49.291.9
Foramen of Magendie96.190.4
Medullary cistern75.552.6
Fourth ventricle87.477.3
Right cerebellopontine angle11.797.7
Left cerebellopontine angle96.859.7
Right inferior horn of lateral ventricles11.510.1
Left inferior horn of lateral ventricles4.16.8
Interpeduncular cistern66.134.4
Subarachnoid space of right temporal lobe94.813.1
Subarachnoid space of left temporal lobe33.322.1
Right sylvian fissure93.84.1
Left sylvian fissure97.34.8
Third ventricle80.857.5
Right anterior horn of lateral ventricles98.69.6
Left anterior horn of lateral ventricles198.9
Right foramen of Monro58.33.5
Left foramen of Monro96.21.3
Right body of lateral ventricles89.947
Left body of lateral ventricles99.20.9
Subarachnoid space of right frontal lobe94.347
Subarachnoid space of left frontal lobe98.798.2
Right central sulcus86.790.8
Left central sulcus94.453.6
Subarachnoid space of right parietal lobe6996.5
Subarachnoid space of left parietal lobe83.596
f-value: Quantitative value of the subcomponent of microperfusion in IVIM MRI expressed as a numerical value from 0 to 100%. IVIM MRI: intravoxel incoherent motion magnetic resonance imaging, IICP: increased intracranial pressure, ICP: intracranial pressure
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Watanabe, S.; Shibata, Y.; Ishikawa, E. A Case of Idiopathic Intracranial Hypertension Complicated with both Infratentorial and Supratentorial Cortical Superficial Siderosis: Novel Imaging Findings on Intravoxel Incoherent Motion Magnetic Resonance Imaging Offering Clues to Pathophysiology. Neurol. Int. 2024, 16, 701-708. https://doi.org/10.3390/neurolint16040053

AMA Style

Watanabe S, Shibata Y, Ishikawa E. A Case of Idiopathic Intracranial Hypertension Complicated with both Infratentorial and Supratentorial Cortical Superficial Siderosis: Novel Imaging Findings on Intravoxel Incoherent Motion Magnetic Resonance Imaging Offering Clues to Pathophysiology. Neurology International. 2024; 16(4):701-708. https://doi.org/10.3390/neurolint16040053

Chicago/Turabian Style

Watanabe, Shinya, Yasushi Shibata, and Eiichi Ishikawa. 2024. "A Case of Idiopathic Intracranial Hypertension Complicated with both Infratentorial and Supratentorial Cortical Superficial Siderosis: Novel Imaging Findings on Intravoxel Incoherent Motion Magnetic Resonance Imaging Offering Clues to Pathophysiology" Neurology International 16, no. 4: 701-708. https://doi.org/10.3390/neurolint16040053

APA Style

Watanabe, S., Shibata, Y., & Ishikawa, E. (2024). A Case of Idiopathic Intracranial Hypertension Complicated with both Infratentorial and Supratentorial Cortical Superficial Siderosis: Novel Imaging Findings on Intravoxel Incoherent Motion Magnetic Resonance Imaging Offering Clues to Pathophysiology. Neurology International, 16(4), 701-708. https://doi.org/10.3390/neurolint16040053

Article Metrics

Back to TopTop